Is Mantle Cell Lymphoma A Sex-Related Disease?

References

• Bosch F., Lopez-Guillermo A., Campo E., Ribera J.M., Conde E., Piris M.A., Vallespi T., Woessner S., Montserrat E. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1997; 82: 567–575
   Web of Science ®Google Scholar
• Decaudin D., Bosq J., Munck J.N., Bayle C., Koscielny S., Boudjemaa S., Bennaceur A., Venuat A.M., Naccache P., Bendahmane B., Ribrag V., Carde P., Pico J.L., Hayat M. Mantle Cell Lymphomas: characteristics, natural history and prognostic factors of 45 cases. Leuk & lymp 1997; 26: 539–550
   PubMed Web of Science ®Google Scholar
• Gressin R., Legouffe E., Leroux D., Jacob M.C., Swiercz P., Peoch M., Capdevilla V., Rossi J.F., Thyss A., Sotto J.J. Treatment of mantle-cell lymphomas with the VAD +/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation. Ann Oncol 1997; 8: S103–S106
   PubMed Web of Science ®Google Scholar
• Norton A.J., Matthews J., Pappa V., Shamash J., Love S., Rohatiner A.Z.S., Lister T.A. Mantle cell lymphoma: natural history defined in a serially biopsed population over a 20-year period. Ann Oncol 1995; 6: 249–256
   PubMed Web of Science ®Google Scholar
• Pittaluga S., Wlodarska I., Stul M.S., Thomas J., Verhoef G., Cassiman J.J., van den Bergue H., De Wolf Peeters C. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 1995; 26: 17–24
   PubMed Web of Science ®Google Scholar
• Samaha H., Dumontet C., Ketterer N., Moullet I., Thieblemont C., Bouafia F., Callet-Bauchu E., Felman P., Berger F., Salles G., Coiffier B. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998; 12: 1281–1287
   PubMed Web of Science ®Google Scholar
• Teodorovic I., Pittaluga S., Kluin-Nelemans J.C., Meerwaldt J.H., Hagenbeek A., van Glabbeke M., Somers R., Bijnens L., Noordijk E.M., De Wolf Peeters C., for the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. J Clin Oncol 1995; 13: 2819–2826
   PubMed Web of Science ®Google Scholar
• Zucca E., Roggero E., Pinotti G., Pedrinis E., Capella C., Venco A., Cavalli F. Patterns of survival of mantle cell lymphoma. Ann Oncol 1995; 6: 257–262
   PubMed Web of Science ®Google Scholar
• Berard C.W., Greene M.H., Jaffe E.S., Magrath I., Ziegler J. A multidisciplinary approach to non Hodgkin's lymphomas. Ann Intern Med 1981; 94: 218–235
   PubMed Web of Science ®Google Scholar
• Armitage J.O., Weisenburger D.D., For the Non-Hodgkin's Lymphoma Classification Project. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Diffuse large B-cell lymphoma. J Clin Oncol 1998; 16: 2780–2795
   PubMed Web of Science ®Google Scholar
• Decaudin D., Lepage E., Brousse N., Brice P., Harousseau J.L., Belhadj K., Tilly H., Michaux L., Chèze S., Coiffier B., Solal-Cèligny P. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients. A study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). J Clin Oncol 1999; 17: 2499–2505
   PubMed Web of Science ®Google Scholar
• Dighiero G., Maloum K., Desablens B., Cazin B., Navarro M., Leblay R., Leporrier M., Jaubert J., Lepeu G., Dreyfus B., Binet J.L., for the French Cooperative Group on Chronic Lymphocytic Leukemia. Chlorambucil in indolent chronic lymphocytic leukemia. N Engl J Med 1998; 338: 1506–1514
   PubMed Web of Science ®Google Scholar
• Morel P., Lepage E., Brice P., Dupriez B., Agay M.F., Fenaux P., Gosselin B., Bauters F., Gisselbrecht C. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 1992; 10: 1078–1085
   PubMed Web of Science ®Google Scholar
• Rodriguez J., McLaughlin P., Hagemeister F.B., Fayad L., Rodriguez M.A., Santiago M., Hess M., Romaguera J., Cabanillas F. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood 1999; 93: 2202–2207
   PubMed Web of Science ®Google Scholar
• Somers R., Carde P., Henry-Amar M., Tarayre M., Thomas J., Hagenbeek A., Monconduit M., de Pauw B.E., Breed W.P.M., Verdonck L., Burgers J.M.W., Eghbali H., Zittoun R. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alternation of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Group Pierre-et-Marie-Curie controlled clinical trial. J Clin Oncol 1994; 12: 279–287
   PubMed Web of Science ®Google Scholar
• Soussain C., Patte C., Ostronoff M., Delmer A., Rigal-Huguet F., Cambier N., Leprisé P.Y., François S., Cony-Makhoul P., Harousseau J.L., Janvier M., Chauvenet L., Witz F., Pico J. Small non-cleaved-cell lymphoma and leukemias in adults. A retrospective study of 65 adults treated with the LMB (B-cell non-Hodgkin's lymphoma and B-ALL) pediatric protocols. Blood 1995; 3: 664–674
   Google Scholar
• Thieblemont C., Bastion Y., Berger F., Rieux C., Salles G., Dumontet C., Felman P., Coiffier B. Mucosa-associated lymphoid tissue gastrointestinal and non-gastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997; 15: 1624–1630
   PubMed Web of Science ®Google Scholar
• Tilly H., Gaulard P., Lepage E., Dumontet C., Diebold J., Plantier I., Berger F., Symann M., Petrella T., Lederlin P., Brière J., for the Groupe d'Etudes des Lymphomes de l'Adulte. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3727–3734
   PubMed Web of Science ®Google Scholar
• Williams M., Swerdlow S., Rosenberg C., Arnold A. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRADI loci in centrocytic lymphoma. Canc Res (Suppl) 1992; 52: 5541S–5544S
   PubMed Web of Science ®Google Scholar
• Cuneo A., Bigoni R., Rigolin G.M., Roberti M.G., Bardi A., Piva N., Milani R., Bullrich F., Veronese M.L., Croce C., Birg F., Döhner H., Hagemeister A., Castoldi G. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood 1999; 93: 1372–1380
   PubMed Web of Science ®Google Scholar
• Hammond D.W., Goepel J.R., Aitken M., Hancock B.W., Potter A.M., Goyns M.H. Cytogenetic analysis of a United Kingdom series of non-Hodgkins lymphomas. Cancer Genet Cytogenet 1992; 61: 31–38
   PubMed Web of Science ®Google Scholar
• Juneja S., Tan L., Cooper I., Szelag G., Parkin J.D., Ironside P., Garson O.M. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations. Br J Haematol 1990; 76: 231–237
   PubMed Web of Science ®Google Scholar
• Blonk M.C., van der Valk P., Beverstock G.C., Ossenkoppele G.J. Sequential development of peripheral T-cell lymphoma in the course of chronic myelogenous leukemia. Cancer 1990; 66: 1198–1203
   PubMed Web of Science ®Google Scholar
• Noguchi M., Yi H., Rosenblatt H.M., Filipovish A.H., Adelstein S., Modi W.S., McBride O.W., Leonard W.J. Interleukin 2 receptor α chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147–157
   PubMed Web of Science ®Google Scholar
• Cutler A.R., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., Bedell M.A., Edelhoff S., Disteche C.M., Simoneaux D.K., Fanslow W.C., Belmont J., Spriggs M.K. CD40 ligand gene defects responsible for X-linked hyper IgM syndrome. Science 1993; 259: 990–993
   PubMed Web of Science ®Google Scholar
• Purtilo D.T. Sex and prognosis in lymphoproliferative disorders. Lancet 1978; 2: 430
   PubMed Web of Science ®Google Scholar